You are here

Celyad

Celyad gets the go-ahead to resume CAR-T trial for colorectal cancer as FDA lifts hold

Endpoints

Mon, 08/1/22 - 11:54 pm

colorectal cancer

clinical trials

FDA quickly follows a voluntary pause for CAR-T 2.0 with a clinical hold to investigate 2 patient deaths

Endpoints

Wed, 03/2/22 - 10:28 am

Corporate and regulatory developments over the Christmas period

EP Vantage

Thu, 01/2/20 - 11:39 pm

Ono Pharmaceutical

Xyphos Biosciences

SITC – the morning after the night before

EP Vantage

Mon, 11/11/19 - 07:51 pm

The Week Ahead In Biotech: Pending Clinical Readouts In Focus

Yahoo/Benzinga

Mon, 07/1/19 - 10:32 am

Sangamo Therapeutics

Catalyst Biosciences

Reata Pharmaceuticals

Vertex Pharmaceuticals

Gilead Sciences

TRACON Pharmaceuticals

Sorrento Therapeutics

Novartis takes the long view on CAR-T, grabbing licenses on new tech for next-gen therapies

Endpoints

Wed, 05/3/17 - 10:05 am